The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transcriptomic landscape of Kaposi sarcoma: Insights into therapeutic targeting of KSHV.
 
Yuewei Fei
No Relationships to Disclose
 
Philippos Costa
No Relationships to Disclose
 
Muhammad Junejo
No Relationships to Disclose
 
Michelle Li
No Relationships to Disclose
 
Curtis Perry
Research Funding - AstraZeneca (Inst)
 
William Damsky
No Relationships to Disclose
 
Jeffrey Ishizuka
Stock and Other Ownership Interests - Curios Therapeutics; Jounce Therapeutics; Kronos Bio
Consulting or Advisory Role - Danger Bio; Fortress Biotech; Ono Pharmaceutical; Phenomic AI; Rheos Medicines; Tango Therapeutics; Two River Group
Research Funding - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - I am an inventor on a patent on approaches targeting dsRNA sensing titled: "MODULATING dsRNA EDITING, SENSING, AND METABOLISM TO INCREASE TUMOR IMMUNITY AND IMPROVE THE EFFICACY OF CANCER IMMUNOTHERAPY AND/OR MODULATORS OF INTRATUMORAL INTERFERON".